Jean-Pierre Garnier GSK: Y volver a sus raices...

Mas...

Tampoco se va con las manos vacías...

Mas...


Y algo habrá ahorrado...




Por eso, seguro..., se carcajea porque "la que se viene encima" es ...

como para "agarrar palco..."
(y de sombra...)


"As blockbusters become rarer, drugmakers such as GSK have switched their focus to developing a range of "middle earners" with annual revenues of £200-300m. Witty declared in July: "GSK must change if it is to be successful in the future."

Mas...